ArticleFrontiers in medicine2025
Health-related quality of life and disease activity in rheumatoid arthritis: a cross-sectional study in West Java, Indonesia.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quality of Life in Long-Standing Rheumatoid Arthritis: What Can Help Apart from Treatment? A Single-Center Cross-Sectional Observational Study.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Joint inflammation is a key manifestation of rheumatoid arthritis (RA), often leading to functional limitations and reduced quality of life (QoL) as the disease progresses. This study aims to examine the association between disease activity and health-related quality of life (HRQoL) in RA patients. Methods: A cross-sectional study was conducted among 110 RA patients aged 18-65, diagnosed according to the 2010 ACR/EULAR criteria and receiving disease-modifying antirheumatic drugs (DMARDs) therapy for at least 1 month. Patient data were obtained from electronic medical records and verified through structured interviews. Health-related quality of life (HRQoL) was assessed using the EQ-5D-5L questionnaire, while disease activity was measured using the DAS28-ESR. Non-parametric analysis was performed to compare EQ-5D scores based on patient characteristics. Result: The most frequently reported problem was pain/discomfort (76.36%), showing significant differences across disease activity groups. Other commonly affected dimensions included usual activities (46.36%), anxiety/depression (44.55%), mobility (33.64%), and self-care (19.09%). The mean EQ-5D index was 0.76 (95% CI, 0.73-0.80), and the visual analogue scale (VAS) score was 73.05 (95% CI, 69.91-76.19). Disease activity and comorbidity showed a statistically significant association with HRQoL ( Conclusion: This study suggests that higher disease activity and comorbidity were negatively associated with HRQoL among RA patients. Disease progression disrupts multiple dimensions of quality of life of the subjects. This study highlights the importance HRQoL assessments in RA management to ensure a more comprehensive approach to patient care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.